Ad
related to: second generation antipsychotics drug list printable free"Shop around for the best prices without a membership fee." - Today
Search results
Results from the WOW.Com Content Network
Print/export Download as PDF; Printable version; ... Following is a list of antipsychotics, sorted by class. Antipsychotics Antipsychotics by class Generic name ...
The atypical antipsychotics (AAP), also known as second generation antipsychotics (SGAs) and serotonin–dopamine antagonists (SDAs), [1] [2] are a group of antipsychotic drugs (antipsychotic drugs in general are also known as tranquilizers and neuroleptics, although the latter is usually reserved for the typical antipsychotics) largely introduced after the 1970s and used to treat psychiatric ...
Saphris – atypical antipsychotic used to treat schizophrenia and bipolar disorder; Serax – anti-anxiety medication of the benzodiazepine class, often used to help during detoxification from alcohol or other addictive substances; Serentil (mesoridazine) – an antipsychotic drug used in the treatment of schizophrenia [1]
The difference between first- and second-generation antipsychotics is a subject of debate. The second-generation antipsychotics are generally distinguishable by the presence of 5HT2A receptor antagonism and a corresponding lower propensity for extrapyramidal side effects compared to first-generation antipsychotics. [15]
This is a list of psychiatric medications used by psychiatrists and other physicians to treat mental illness or distress. The list is ordered alphabetically according to the condition or conditions, then by the generic name of each medication. The list is not exhaustive and not all drugs are used regularly in all countries.
For premium support please call: 800-290-4726 more ways to reach us
Clozapine, sold under the brand name Clozaril among others, is a psychiatric medication and was the first atypical antipsychotic to be discovered. [6] It is primarily used to treat people with schizophrenia and schizoaffective disorder who have had an inadequate response to two other antipsychotics, or who have been unable to tolerate other drugs due to extrapyramidal side effects.
In early September 2000, a Johnson & Johnson email celebrated the full implementation of the TMAP program that put Risperdal at the top of the recommended list of second-generation antipsychotics and first-generation generics for doctors giving these drugs to Medicaid patients in Texas. “Let the butt kicking begin,” wrote a Janssen sales ...